Immunological aspects of pre-eclampsia (Q35535852)

8 August 2017

1 reference

title

Immunological aspects of pre-eclampsia (English)

1 reference

8 August 2017

0 references

C. W. Redman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1446422

27 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1446422

27 September 2022

publication date

1 September 1992

1 reference

Bailliere's clinical obstetrics and gynaecology

8 August 2017

published in

1 reference

8 August 2017

volume

6

1 reference

8 August 2017

issue

3

1 reference

8 August 2017

page(s)

601-615

1 reference

Serum IGE and Smooth Muscle Antibodies in Pre-Eclampsia

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

An epidemiological study of the immunogenetic aetiology of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Genetic and familial predisposition to eclampsia and pre-eclampsia in a defined population.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia/eclampsia: a fatal father factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Serum IgM and IgG responses in postnatally acquired rubella

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Detection of antibodies in pregnancy serum reacting with isolated placental basement membrane collagen

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia and trisomy 13.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia and trisomy 13: a possible association

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia in second pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Genetics of hypertension in pregnancy: possible single gene control of pre-eclampsia and eclampsia in the descendants of eclamptic women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Occurrence of pre-eclampsia in pregnancies to three husbands. Case report

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Genetic control of susceptibility to eclampsia and miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Some parameters of lymphocyte antibody activity through pregnancy and further eluates of placental material

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

HLA G: at the interface

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia and changed paternity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Influence of previous blood-transfusion on incidence of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Antibodies to laminin in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Leukocyte migration enhancement as an indicator of immunologic enhancement. I. Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Neutrophil activation in pregnancy-induced hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Lymphocyte subpopulations in normal and preeclampsia pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Natural killer cell activity and antibody dependent cell-mediated cytotoxicity in preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

C4 and plasma protein in hypertension during pregnancy with and without proteinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immune complexes in skin of patients with pre-eclamptic toxemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Antibody to trophoblast during early postpartum period in toxemic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Eclampsia in multipara

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Human leucocyte antigens and mixed lymphocyte reaction in severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Determinants of immunological responsiveness in recurrent spontaneous abortion

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Placental polysaccharide and the aetiology of the toxaemia of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Histocompatibility studies in pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Serum complement in normal pregnancy and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

An epidemiologic study of contraception and preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Villitis of unknown aetiology: its incidence and significance in placentae from a British population

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Role of children's sex in mixed mother-child lymphocyte culture reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

The influence of pregnancy and contraceptive pills upon oxygen consumption during phagocytosis by human leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Chronic villitis of unknown aetiology and decidual maternal vasculopathies in sustained chronic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Chronic villitis of unknown aetiology in placentae of idiopathic small for gestational age infants

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Vascular Changes of Endometrium in Early Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immunofluorescent studies of the endometrial arteries in the first trimester of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

In search of the 'missing self': MHC molecules and NK cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia/eclampsia in twin pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Some observations on the incidence of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pregnancy-induced hypertension in twin pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

The role of the phagocyte in host-parasite interactions. XXV. Metabolic and bactericidal activities of leukocytes from pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Lymphocyte Subsets Defined by Monoclonal Antibodies in Human Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Lymphocyte subsets in normal and pre-eclamptic pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Mitogenic activity is increased in the sera of preeclamptic women before delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia in pregnancies from donor inseminations

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

On the familial appearances of maternal and foetal incompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immunofluorescent Studies in Renal Biopsies in Pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Anti-vascular endothelial cell antibodies in severe preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Are there immunologically mediated abortions? If so, which mechanisms?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Current topic: pre-eclampsia and the placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

HLA antigens in severe pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Preeclampsia: an endothelial cell disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Inflammatory lesions of the human placenta. III. The histopathology of villitis of unknown aetiology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Abnormalities in platelet antiglobulin tests in preeclamptic mothers and their neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Maternal immune responses to the fetus in early pregnancy and recurrent miscarriage

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

The effect of abortion on the incidence of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immune basis for pre-eclampsia evidence from oocyte recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Decreased levels of helper T cells: a possible cause of immunodeficiency in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

T-cell subsets in patients with preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Contribution of fetal/maternal incompatibility to aetiology of pre-eclamptic toxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

The relationship between abortion in the first pregnancy and development of pregnancy-induced hypertension in the subsequent pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immunoglobulins in normal pregnancy, pre-eclampsia and pregnancy complicated by the nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Increased serum activity of interleukin-2 in patients with pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

The indicence of severe pre-eclampsia amongst mothers and mothers-in-law of pre-eclamptics and controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

HLA typing to establish maternity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Pre-eclampsia and anti-phospholipid antibody.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immunohistochemical detection of terminal complement complex and S protein in normal and pre-eclamptic placentae

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Expression of retrovirus-related antigen in pregnancy. II. Cytotoxic and blocking specificities of immunoglobulins eluted from the placenta

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immunological studies in pre-eclamptic toxaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Genetics of pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Cellular hyperreactivity to placenta in toxemia of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Activity of natural killer cells in normal pregnancy and edema-proteinuria-hypertension gestosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Sex Ratio of Newborns: Preponderance of Males in Toxemia of Pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Absence of close linkage between maternal genes for susceptibility to pre-eclampsia/eclampsia and HLA DRβ

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Immunologic aspects of term pregnancy toxemia. A study of immunoglobins and complement

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

Vascular changes in the decidua associated with eclamptogenic toxemia of pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3552%2805%2980012-4

7 January 2021

10.1016/S0950-3552(05)80012-4

Identifiers

DOI

1 reference

8 August 2017

1 reference